163 results on '"Alberto Ferri"'
Search Results
2. Physical exercise in amyotrophic lateral sclerosis: a potential co-adjuvant therapeutic option to counteract disease progression
- Author
-
Gianmarco Fenili, Silvia Scaricamazza, Alberto Ferri, Cristiana Valle, and Maria Paola Paronetto
- Subjects
ALS ,physical activity ,muscle atrophy ,neurodegenerative disease ,exercise ,Biology (General) ,QH301-705.5 - Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal disorder characterized by the selective degeneration of upper and lower motor neurons, leading to progressive muscle weakness and atrophy. The mean survival time is two to five years. Although the hunt for drugs has greatly advanced over the past decade, no cure is available for ALS yet. The role of intense physical activity in the etiology of ALS has been debated for several decades without reaching a clear conclusion. The benefits of organized physical activity on fitness and mental health have been widely described. Indeed, by acting on specific mechanisms, physical activity can influence the physiology of several chronic conditions. It was shown to improve skeletal muscle metabolism and regeneration, neurogenesis, mitochondrial biogenesis, and antioxidant defense. Interestingly, all these pathways are involved in ALS pathology. This review will provide a broad overview of the effect of different exercise protocols on the onset and progression of ALS, both in humans and in animal models. Furthermore, we will discuss challenges and opportunities to exploit physiological responses of imposed exercise training for therapeutic purposes.
- Published
- 2024
- Full Text
- View/download PDF
3. Hydrogen Sulfide Modulates Astrocytic Toxicity in Mouse Spinal Cord Cultures: Implications for Amyotrophic Lateral Sclerosis
- Author
-
Susanna De Stefano, Marta Tiberi, Illari Salvatori, Marco De Bardi, Juliette Gimenez, Mahsa Pirshayan, Viviana Greco, Giovanna Borsellino, Alberto Ferri, Cristiana Valle, Nicola B. Mercuri, Valerio Chiurchiù, Alida Spalloni, and Patrizia Longone
- Subjects
hydrogen sulfide ,astrocytes ,mitochondria ,motor neuron ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Hydrogen sulfide (H2S), a known inhibitor of the electron transport chain, is endogenously produced in the periphery as well as in the central nervous system, where is mainly generated by glial cells. It affects, as a cellular signaling molecule, many different biochemical processes. In the central nervous system, depending on its concentration, it can be protective or damaging to neurons. In the study, we have demonstrated, in a primary mouse spinal cord cultures, that it is particularly harmful to motor neurons, is produced by glial cells, and is stimulated by inflammation. However, its role on glial cells, especially astrocytes, is still under-investigated. The present study was designed to evaluate the impact of H2S on astrocytes and their phenotypic heterogeneity, together with the functionality and homeostasis of mitochondria in primary spinal cord cultures. We found that H2S modulates astrocytes’ morphological changes and their phenotypic transformation, exerts toxic properties by decreasing ATP production and the mitochondrial respiration rate, disturbs mitochondrial depolarization, and alters the energetic metabolism. These results further support the hypothesis that H2S is a toxic mediator, mainly released by astrocytes, possibly acting as an autocrine factor toward astrocytes, and probably involved in the non-cell autonomous mechanisms leading to motor neuron death.
- Published
- 2024
- Full Text
- View/download PDF
4. Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects the entire skeletal muscle-motor neuron axis
- Author
-
Silvia Scaricamazza, Valentina Nesci, Illari Salvatori, Gianmarco Fenili, Marco Rosina, Michela Gloriani, Maria Paola Paronetto, Luca Madaro, Alberto Ferri, and Cristiana Valle
- Subjects
amyotrophic lateral sclerosis ,physical activity ,endurance exercise ,neurodegeneration ,neuroinflammation ,SOD1-G93A mice ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Background:Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease characterized by the degeneration of motor neurons that leads to muscle wasting and atrophy. Epidemiological and experimental evidence suggests a causal relationship between ALS and physical activity (PA). However, the impact of PA on motor neuron loss and sarcopenia is still debated, probably because of the heterogeneity and intensities of the proposed exercises. With this study, we aimed to clarify the effect of intense endurance exercise on the onset and progression of ALS in the SOD1-G93A mouse model.Methods:We randomly selected four groups of twelve 35-day-old female mice. SOD1-G93A and WT mice underwent intense endurance training on a motorized treadmill for 8 weeks, 5 days a week. During the training, we measured muscle strength, weight, and motor skills and compared them with the corresponding sedentary groups to define the disease onset. At the end of the eighth week, we analyzed the skeletal muscle-motor neuron axis by histological and molecular techniques.Results:Intense endurance exercise anticipates the onset of the disease by 1 week (age of the onset: trained SOD1-G93A = 63.17 ± 2.25 days old; sedentary SOD1-G93A = 70.75 ± 2.45 days old). In SOD1-G93A mice, intense endurance exercise hastens the muscular switch to a more oxidative phenotype and worsens the denervation process by dismantling neuromuscular junctions in the tibialis anterior, enhancing the Wallerian degeneration in the sciatic nerve, and promoting motor neuron loss in the spinal cord. The training exacerbates neuroinflammation, causing immune cell infiltration in the sciatic nerve and a faster activation of astrocytes and microglia in the spinal cord.Conclusion:Intense endurance exercise, acting on skeletal muscles, worsens the pathological hallmarks of ALS, such as denervation and neuroinflammation, brings the onset forward, and accelerates the progression of the disease. Our findings show the potentiality of skeletal muscle as a target for both prognostic and therapeutic strategies; the preservation of skeletal muscle health by specific intervention could counteract the dying-back process and protect motor neurons from death. The physiological characteristics and accessibility of skeletal muscle further enhance its appeal as a therapeutic target.
- Published
- 2024
- Full Text
- View/download PDF
5. Lipid catabolism and mitochondrial uncoupling are stimulated in brown adipose tissue of amyotrophic lateral sclerosis mouse models
- Author
-
Fabio Ciccarone, Serena Castelli, Giacomo Lazzarino, Silvia Scaricamazza, Renata Mangione, Sergio Bernardini, Savina Apolloni, Nadia D'Ambrosi, Alberto Ferri, and Maria Rosa Ciriolo
- Subjects
Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Published
- 2023
- Full Text
- View/download PDF
6. Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
- Author
-
Cassandra Margotta, Paola Fabbrizio, Marco Ceccanti, Chiara Cambieri, Gabriele Ruffolo, Jessica D’Agostino, Maria Chiara Trolese, Pierangelo Cifelli, Veronica Alfano, Christian Laurini, Silvia Scaricamazza, Alberto Ferri, Gianni Sorarù, Eleonora Palma, Maurizio Inghilleri, Caterina Bendotti, and Giovanni Nardo
- Subjects
Amyotrophic lateral sclerosis ,Mouse model ,ACh receptor ,Skeletal muscle ,Macrophages ,Myogenesis ,Pathology ,RB1-214 - Abstract
Abstract Background Amyotrophic lateral sclerosis (ALS) is a heterogeneous disease in terms of onset and progression rate. This may account for therapeutic clinical trial failure. Transgenic SOD1G93A mice on C57 or 129Sv background have a slow and fast disease progression rate, mimicking the variability observed in patients. Based on evidence inferring the active influence of skeletal muscle on ALS pathogenesis, we explored whether dysregulation in hindlimb skeletal muscle reflects the phenotypic difference between the two mouse models. Methods Ex vivo immunohistochemical, biochemical, and biomolecular methodologies, together with in vivo electrophysiology and in vitro approaches on primary cells, were used to afford a comparative and longitudinal analysis of gastrocnemius medialis between fast- and slow-progressing ALS mice. Results We reported that slow-progressing mice counteracted muscle denervation atrophy by increasing acetylcholine receptor clustering, enhancing evoked currents, and preserving compound muscle action potential. This matched with prompt and sustained myogenesis, likely triggered by an early inflammatory response switching the infiltrated macrophages towards a M2 pro-regenerative phenotype. Conversely, upon denervation, fast-progressing mice failed to promptly activate a compensatory muscle response, exhibiting a rapidly progressive deterioration of muscle force. Conclusions Our findings further pinpoint the pivotal role of skeletal muscle in ALS, providing new insights into underestimated disease mechanisms occurring at the periphery and providing useful (diagnostic, prognostic, and mechanistic) information to facilitate the translation of cost-effective therapeutic strategies from the laboratory to the clinic.
- Published
- 2023
- Full Text
- View/download PDF
7. Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a Friedreich’s ataxia mouse model
- Author
-
Riccardo Turchi, Francesca Sciarretta, Veronica Ceci, Marta Tiberi, Matteo Audano, Silvia Pedretti, Concetta Panebianco, Valentina Nesci, Valerio Pazienza, Alberto Ferri, Simone Carotti, Valerio Chiurchiù, Nico Mitro, Daniele Lettieri-Barbato, and Katia Aquilano
- Subjects
Pharmacology ,Natural sciences ,Biological sciences ,Neuroscience ,Science - Abstract
Summary: Friedreich’s ataxia (FA) is a neurodegenerative disease resulting from a mutation in the FXN gene, leading to mitochondrial frataxin deficiency. FA patients exhibit increased visceral adiposity, inflammation, and heightened diabetes risk, negatively affecting prognosis. We investigated visceral white adipose tissue (vWAT) in a murine model (KIKO) to understand its role in FA-related metabolic complications. RNA-seq analysis revealed altered expression of inflammation, angiogenesis, and fibrosis genes. Diabetes-like traits, including larger adipocytes, immune cell infiltration, and increased lactate production, were observed in vWAT. FXN downregulation in cultured adipocytes mirrored vWAT diabetes-like features, showing metabolic shifts toward glycolysis and lactate production. Metagenomic analysis indicated a reduction in fecal butyrate-producing bacteria, known to exert antidiabetic effects. A butyrate-enriched diet restrained vWAT abnormalities and mitigated diabetes features in KIKO mice. Our work emphasizes the role of vWAT in FA-related metabolic issues and suggests butyrate as a safe and promising adjunct for FA management.
- Published
- 2023
- Full Text
- View/download PDF
8. SerpinE1 drives a cell-autonomous pathogenic signaling in Hutchinson–Gilford progeria syndrome
- Author
-
Giorgia Catarinella, Chiara Nicoletti, Andrea Bracaglia, Paola Procopio, Illari Salvatori, Marilena Taggi, Cristiana Valle, Alberto Ferri, Rita Canipari, Pier Lorenzo Puri, and Lucia Latella
- Subjects
Cytology ,QH573-671 - Abstract
Abstract Hutchinson–Gilford progeria syndrome (HGPS) is a rare, fatal disease caused by Lamin A mutation, leading to altered nuclear architecture, loss of peripheral heterochromatin and deregulated gene expression. HGPS patients eventually die by coronary artery disease and cardiovascular alterations. Yet, how deregulated transcriptional networks at the cellular level impact on the systemic disease phenotype is currently unclear. A genome-wide analysis of gene expression in cultures of primary HGPS fibroblasts identified SerpinE1, also known as Plasminogen Activator Inhibitor (PAI-1), as central gene that propels a cell-autonomous pathogenic signaling from the altered nuclear lamina. Indeed, siRNA-mediated downregulation and pharmacological inhibition of SerpinE1 by TM5441 could revert key pathological features of HGPS in patient-derived fibroblasts, including re-activation of cell cycle progression, reduced DNA damage signaling, decreased expression of pro-fibrotic genes and recovery of mitochondrial defects. These effects were accompanied by the correction of nuclear abnormalities. These data point to SerpinE1 as a novel potential effector and target for therapeutic interventions in HGPS pathogenesis.
- Published
- 2022
- Full Text
- View/download PDF
9. Correction: Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
- Author
-
Cassandra Margotta, Paola Fabbrizio, Marco Ceccanti, Chiara Cambieri, Gabriele Rufolo, Jessica D’Agostino, Maria Chiara Trolese, Pierangelo Cifelli, Veronica Alfano, Christian Laurini, Silvia Scaricamazza, Alberto Ferri, Gianni Sorarù, Eleonora Palma, Maurizio Inghilleri, Caterina Bendotti, and Giovanni Nardo
- Subjects
Pathology ,RB1-214 - Published
- 2023
- Full Text
- View/download PDF
10. Proteome data of neuroblastoma cells overexpressing Neuroglobin
- Author
-
Michele Costanzo, Marianna Caterino, Illari Salvatori, Valeria Manganelli, Alberto Ferri, Roberta Misasi, and Margherita Ruoppolo
- Subjects
Proteomics ,Neuroglobin ,Label-free quantification ,LC-MS/MS ,S-Trap ,MaxQuant ,Computer applications to medicine. Medical informatics ,R858-859.7 ,Science (General) ,Q1-390 - Abstract
In this article, we present data on the proteome of human neuroblastoma cells stably overexpressing Neuroglobin (NGB). The neuroprotective role of NGB is clearly established, nevertheless the related mechanistic processes, which are dependent on NGB overexpression, are not known. To address this question, we performed shotgun label-free quantification (LFQ) proteomics using an SH-SY5Y cell model of neuroblastoma that overexpresses an NGB-FLAG construct, and wild type cells transfected with an empty vector as control (CTRL). The proteomes from six biological samples per condition were digested using the S-Trap sample preparation followed by LC-MS/MS analysis with a LTQ-Orbitrap XL mass spectrometer. The quantitative analysis was performed using the LFQ algorithm of MaxQuant, leading to 1654 correctly quantified proteins over 2580 identified proteins. Finally, the statistic comparison of the two analyzed groups within Perseus platform identified 178 differential proteins (107 up- and 71 down-regulated). In addition, multivariate statistical analysis was carried out using MetaboAnalyst 5.0 software. MS proteomics data are available via ProteomeXchange with the dataset identifier PXD029012.
- Published
- 2022
- Full Text
- View/download PDF
11. Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project
- Author
-
Sabrina Zora, Carlo Custodero, Yves-Marie Pers, Verushka Valsecchi, Alberto Cella, Alberto Ferri, Marta M. Pisano-González, Delia Peñacoba Maestre, Raquel Vazquez Alvarez, Hein Raat, Graham Baker, and Alberto Pilotto
- Subjects
Therapeutics. Pharmacology ,RM1-950 - Abstract
Introduction: The Chronic Disease Self-Management Program (CDSMP) improves self-efficacy and health outcomes in people with chronic diseases. In the context of the EFFICHRONIC project, we evaluated the efficacy of CDSMP in relieving frailty, as assessed by the self-administered version of Multidimensional Prognostic Index (SELFY-MPI), identifying also potential predictors of better response over 6-month follow-up. Methods: The SELFY-MPI explores mobility, basal and instrumental activities of daily living (Barthel mobility, ADL, IADL), cognition (Test Your Memory-TYM Test), nutrition (Mini Nutritional Assessment-Short Form-MNA-SF), comorbidities, medications, and socio-economic conditions (social-familiar evaluation scale-SFES). Participants were stratified in three groups according to the 6-month change of SELFY-MPI: those who improved after CDSMP (Δ SELFY-MPI 0). Multivariable logistic regression was modeled to identify predictors of SELFY-MPI improvement. Results: Among 270 participants (mean age = 61.45 years, range = 26–93 years; females = 78.1%) a benefit from CDSMP intervention, in terms of decrease in the SELFY-MPI score, was observed in 32.6% of subjects. SELFY-MPI improvement was found in participants with higher number of comorbidities (1–2 chronic diseases: adjusted odd ratio (aOR)=2.38, 95% confidence interval (CI) =1.01, 5.58; ⩾ 3 chronic diseases: aOR = 3.34, 95% CI = 1.25, 8.90 vs no chronic disease), poorer cognitive performance (TYM ⩽ 42: aOR = 2.41, 95% CI = 1.12, 5.19 vs TYM > 42) or higher risk of malnutrition (MNA-SF ⩽ 11: aOR = 6.11, 95% CI = 3.15, 11.83 vs MNA-SF > 11). Conclusion: These findings suggest that the CDSMP intervention contributes to decreasing the self-perceived severity of frailty (SELFY-MPI score) in more vulnerable participants with several chronic diseases and lower cognitive performance and nutritional status.
- Published
- 2021
- Full Text
- View/download PDF
12. Differences in CSF Biomarkers Profile of Patients with Parkinson's Disease Treated with MAO-B Inhibitors in Add-On
- Author
-
Henri Zenuni, Niccolò Candelise, Piergiorgio Grillo, Clara Simonetta, Roberta Bovenzi, Alberto Ferri, Cristiana Valle, Nicola Biagio Mercuri, and Tommaso Schirinzi
- Subjects
parkinson's disease ,csf biomarkers ,neurodegeneration ,neuroprotection ,mao inhibitors ,selegiline ,rasagiline ,safinamide ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Background: Monoamine oxidase type B inhibitors (iMAO-Bs) are a class of largely-used antiparkinsonian agents that, based on experimental evidence, are supposed to exert different degrees of neuroprotection in Parkinson’s disease (PD). However, clinical proofs on this regard are very scarce. Since cerebrospinal fluid (CSF) reflects pathological changes occurring at brain level, we examined the neurodegeneration-related CSF biomarkers profile of PD patients under chronic treatment with different iMAO-Bs to identify biochemical signatures suggestive for differential neurobiological effects. Methods: Thirty-five PD patients under chronic treatment with different iMAO-Bs in add-on to levodopa were enrolled and grouped in rasagiline (n = 13), selegiline (n = 9), safinamide (n = 13). Respective standard clinical scores for motor and non-motor disturbances, together with CSF biomarkers of neurodegeneration levels (amyloid- β -42, amyloid- β -40, total and 181-phosphorylated tau, and lactate) were collected and compared among the three iMAO-B groups. Results: No significant clinical differences emerged among the iMAO-B groups. CSF levels of tau proteins and lactate were instead different, resulting higher in patients under selegiline than in those under rasagiline and safinamide. Conclusions: Although preliminary and limited, this study indicates that patients under different iMAO-Bs may present distinct profiles of CSF neurodegeneration-related biomarkers, probably because of the differential neurobiological effects of the drugs. Larger studies are now needed to confirm and extend these initial observations.
- Published
- 2022
- Full Text
- View/download PDF
13. Histaminergic transmission slows progression of amyotrophic lateral sclerosis
- Author
-
Savina Apolloni, Susanna Amadio, Paola Fabbrizio, Giovanna Morello, Antonio Gianmaria Spampinato, Emanuele Claudio Latagliata, Illari Salvatori, Daisy Proietti, Alberto Ferri, Luca Madaro, Stefano Puglisi‐Allegra, Sebastiano Cavallaro, and Cinzia Volonté
- Subjects
ALS ,Histamine ,Motor neurons ,Microglia ,Skeletal muscles ,SOD1‐G93A ,Diseases of the musculoskeletal system ,RC925-935 ,Human anatomy ,QM1-695 - Abstract
Abstract Background Histamine is an immune modulator, neuroprotective, and remyelinating agent, beneficially acting on skeletal muscles and promoting anti‐inflammatory features in amyotrophic lateral sclerosis (ALS) microglia. Drugs potentiating the endogenous release of histamine are in trial for neurological diseases, with a role not systematically investigated in ALS. Here, we examine histamine pathway associations in ALS patients and the efficacy of a histamine‐mediated therapeutic strategy in ALS mice. Methods We adopted an integrative multi‐omics approach combining gene expression profiles, copy number variants, and single nucleotide polymorphisms of ALS patients. We treated superoxide dismutase 1 (SOD1)‐G93A mice that recapitulate key ALS features, with the brain‐permeable histamine precursor histidine in the symptomatic phase of the disease and analysed the rescue from disease pathological signs. We examined the action of histamine in cultured SOD1‐G93A motor neuron‐like cells. Results We identified 13 histamine‐related genes deregulated in the spinal cord of two ALS patient subgroups, among which genes involved in histamine metabolism, receptors, transport, and secretion. Some histamine‐related genes overlapped with genomic regions disrupted by DNA copy number and with ALS‐linked pathogenic variants. Histidine treatment in SOD1‐G93A mice proved broad efficacy in ameliorating ALS features, among which most importantly lifespan, motor performance, microgliosis, muscle atrophy, and motor neurons survival in vivo and in vitro. Conclusions Our gene set/pathway enrichment analyses and preclinical studies started at the onset of symptoms establish that histamine‐related genes are modifiers in ALS, supporting their role as candidate biomarkers and therapeutic targets. We disclose a novel important role for histamine in the characterization of the multi‐gene network responsible for ALS and, furthermore, in the drug development process.
- Published
- 2019
- Full Text
- View/download PDF
14. Editorial: Mitochondrial Proteomics: Understanding Mitochondria Function and Dysfunction Through the Characterization of Their Proteome
- Author
-
Alberto Ferri, Pablo M. Garcia-Roves, and Luisa Pieroni
- Subjects
mitochondria ,proteome ,post-translational modifications ,metabolism ,neurodegeneration ,Biology (General) ,QH301-705.5 - Published
- 2020
- Full Text
- View/download PDF
15. Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
- Author
-
Niccolò Candelise, Illari Salvatori, Silvia Scaricamazza, Valentina Nesci, Henri Zenuni, Alberto Ferri, and Cristiana Valle
- Subjects
amyotrophic lateral sclerosis ,motor neuron disease ,mitochondria ,metabolism ,bioenergetic ,Microbiology ,QR1-502 - Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of the upper and lower motor neurons. Despite the increasing effort in understanding the etiopathology of ALS, it still remains an obscure disease, and no therapies are currently available to halt its progression. Following the discovery of the first gene associated with familial forms of ALS, Cu–Zn superoxide dismutase, it appeared evident that mitochondria were key elements in the onset of the pathology. However, as more and more ALS-related genes were discovered, the attention shifted from mitochondria impairment to other biological functions such as protein aggregation and RNA metabolism. In recent years, mitochondria have again earned central, mechanistic roles in the pathology, due to accumulating evidence of their derangement in ALS animal models and patients, often resulting in the dysregulation of the energetic metabolism. In this review, we first provide an update of the last lustrum on the molecular mechanisms by which the most well-known ALS-related proteins affect mitochondrial functions and cellular bioenergetics. Next, we focus on evidence gathered from human specimens and advance the concept of a cellular-specific mitochondrial “metabolic threshold”, which may appear pivotal in ALS pathogenesis.
- Published
- 2022
- Full Text
- View/download PDF
16. Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target
- Author
-
Silvia Scaricamazza, Illari Salvatori, Giacomo Giacovazzo, Jean Philippe Loeffler, Frederique Renè, Marco Rosina, Cyril Quessada, Daisy Proietti, Constantin Heil, Simona Rossi, Stefania Battistini, Fabio Giannini, Nila Volpi, Frederik J. Steyn, Shyuan T. Ngo, Elisabetta Ferraro, Luca Madaro, Roberto Coccurello, Cristiana Valle, and Alberto Ferri
- Subjects
Drugs ,Molecular Neuroscience ,Cellular Neuroscience ,Science - Abstract
Summary: Patients with ALS show, in addition to the loss of motor neurons in the spinal cord, brainstem, and cerebral cortex, an abnormal depletion of energy stores alongside hypermetabolism. In this study, we show that bioenergetic defects and muscle remodeling occur in skeletal muscle of the SOD1G93A mouse model of ALS mice prior to disease onset and before the activation of muscle denervation markers, respectively. These changes in muscle physiology were followed by an increase in energy expenditure unrelated to physical activity. Finally, chronic treatment of SOD1G93A mice with Ranolazine, an FDA-approved inhibitor of fatty acid β-oxidation, led to a decrease in energy expenditure in symptomatic SOD1G93A mice, and this occurred in parallel with a robust, albeit temporary, recovery of the pathological phenotype.
- Published
- 2020
- Full Text
- View/download PDF
17. Implementation of the SELFY-MPI in five European countries: a multicenter international feasibility study
- Author
-
Sabrina Zora, Katerin Leslie Quispe Guerrero, Nicola Veronese, Alberto Ferri, An L.D. Boone, Marta Pisano Gonzalez, Yves-Marie Pers, Hein Raat, Graham Baker, Alberto Cella, and Alberto Pilotto
- Subjects
SELFY-MPI ,EFFICHRONIC ,comprehensive geriatric assessment ,multidimensional prognostic index. ,Geriatrics ,RC952-954.6 - Abstract
It is essential for welfare systems to predict the health and care needs of people with chronic diseases. The Multidimensional Prognostic Index (MPI) proved excellent accuracy in predicting negative health outcomes. Recently, a selfadministered version of MPI (SELFY-MPI) was developed and validated in community- dwelling subjects showing an excellent agreement between the two instruments regardless of age. This is a feasibility study concerns the implementation of SELFYMPI in five European countries. The SELFY-MPI includes the self-administration of Barthel Index, Instrumental Activities of daily Living (IADL), Test Your Memory (TYM) Test, Mini Nutritional Assessment-Short Form (MNA-SF), comorbidity, number of medications, and the Gijon’s Socio-Familial Evaluation Scale (SFES). A descriptive analysis was performed on the data collected. 300 subjects (mean age 62 years, range 19-88 years; male/female ratio 0.81) completed the SELFY-MPI. The mean value of the SELFY-MPI was 0.131 (range: 0.0- 0.563) showing a significant correlation with age (Pearson coefficient=0.373, P
- Published
- 2019
- Full Text
- View/download PDF
18. Overexpression of Neuroglobin Promotes Energy Metabolism and Autophagy Induction in Human Neuroblastoma SH-SY5Y Cells
- Author
-
Valeria Manganelli, Illari Salvatori, Michele Costanzo, Antonella Capozzi, Daniela Caissutti, Marianna Caterino, Cristiana Valle, Alberto Ferri, Maurizio Sorice, Margherita Ruoppolo, Tina Garofalo, and Roberta Misasi
- Subjects
neuroglobin ,mitochondria ,autophagy ,energy metabolism ,SH-SY5Y neuroblastoma cells ,label-free proteomics ,Cytology ,QH573-671 - Abstract
Neuroglobin (NGB) is an O2-binding globin mainly expressed in the central and peripheral nervous systems and cerebrospinal fluid. Previously, it was demonstrated that NGB overexpression protects cells from hypoxia-induced death. To investigate processes promoted by NGB overexpression, we used a cellular model of neuroblastoma stably overexpressing an NGB-FLAG construct. We used a proteomic approach to identify the specific profile following NGB overexpression. To evaluate the role of NGB overexpression in increasing energetic metabolism, we measured oxygen consumption rate (OCR) and the extracellular acidification rate through Seahorse XF technology. The effect on autophagy induction was evaluated by analyzing SQSTM1/p62 and LC3-II expression. Proteomic analysis revealed several differentially regulated proteins, involved in oxidative phosphorylation and integral mitochondrial proteins linked to energy metabolism. The analysis of mitochondrial metabolism demonstrated that NGB overexpression increases mitochondrial ATP production. Indeed, NGB overexpression enhances bioenergetic metabolism, increasing OCR and oxygen consumption. Analysis of autophagy induction revealed an increase of LC3-II together with a significant decrease of SQSTM1/p62, and NGB-LC3-II association during autophagosome formation. These results highlight the active participation of NGB in several cellular processes that can be upregulated in response to NGB overexpression, playing a role in the adaptive response to stress in neuroblastoma cells.
- Published
- 2021
- Full Text
- View/download PDF
19. Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
- Author
-
Cyril Quessada, Alexandra Bouscary, Frédérique René, Cristiana Valle, Alberto Ferri, Shyuan T. Ngo, and Jean-Philippe Loeffler
- Subjects
skeletal muscle ,ALS ,neuromuscular junction ,hypermetabolism ,PDK4 ,metabolic imbalance ,Cytology ,QH573-671 - Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive and selective loss of motor neurons, amyotrophy and skeletal muscle paralysis usually leading to death due to respiratory failure. While generally considered an intrinsic motor neuron disease, data obtained in recent years, including our own, suggest that motor neuron protection is not sufficient to counter the disease. The dismantling of the neuromuscular junction is closely linked to chronic energy deficit found throughout the body. Metabolic (hypermetabolism and dyslipidemia) and mitochondrial alterations described in patients and murine models of ALS are associated with the development and progression of disease pathology and they appear long before motor neurons die. It is clear that these metabolic changes participate in the pathology of the disease. In this review, we summarize these changes seen throughout the course of the disease, and the subsequent impact of glucose–fatty acid oxidation imbalance on disease progression. We also highlight studies that show that correcting this loss of metabolic flexibility should now be considered a major goal for the treatment of ALS.
- Published
- 2021
- Full Text
- View/download PDF
20. Microglia Morphological Changes in the Motor Cortex of hSOD1G93A Transgenic ALS Mice
- Author
-
Sara Migliarini, Silvia Scaricamazza, Cristiana Valle, Alberto Ferri, Massimo Pasqualetti, and Elisabetta Ferraro
- Subjects
microglia ,amyotrophic lateral sclerosis ,neuroimmunology ,metabolic reprogramming ,SOD1G93A ,motor cortex ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of spinal motor neurons as well as corticospinal (CSN) large pyramidal neurons within cortex layer V. An intense microglia immune response has been associated with both upper and lower motor neuron degeneration in ALS patients, whereas microgliosis occurrence in the motor cortex of hSOD1G93A mice—the best characterized model of this disease—is not clear and remains under debate. Since the impact of microglia cells in the neuronal environment seems to be crucial for both the initiation and the progression of the disease, here we analyzed the motor cortex of hSOD1G93A mice at the onset of symptoms by the immunolabeling of Iba1/TMEM119 double positive cells and confocal microscopy. By means of Sholl analysis, we were able to identify and quantify the presence of presumably activated Iba1/TMEM119-positive microglia cells with shorter and thicker processes as compared to the normal surveilling and more ramified microglia present in WT cortices. We strongly believe that being able to analyze microglia activation in the motor cortex of hSOD1G93A mice is of great importance for defining the timing and the extent of microglia involvement in CSN degeneration and for the identification of the initiation stages of this disease.
- Published
- 2021
- Full Text
- View/download PDF
21. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?
- Author
-
Silvia Scaricamazza, Illari Salvatori, Alberto Ferri, and Cristiana Valle
- Subjects
amyotrophic lateral sclerosis ,skeletal muscle ,pharmacological approaches ,physical activity ,genetic intervention ,Cytology ,QH573-671 - Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the selective degeneration of upper and lower motor neurons and by the progressive weakness and paralysis of voluntary muscles. Despite intense research efforts and numerous clinical trials, it is still an incurable disease. ALS had long been considered a pure motor neuron disease; however, recent studies have shown that motor neuron protection is not sufficient to prevent the course of the disease since the dismantlement of neuromuscular junctions occurs before motor neuron degeneration. Skeletal muscle alterations have been described in the early stages of the disease, and they seem to be mainly involved in the “dying back” phenomenon of motor neurons and metabolic dysfunctions. In recent years, skeletal muscles have been considered crucial not only for the etiology of ALS but also for its treatment. Here, we review clinical and preclinical studies that targeted skeletal muscles and discuss the different approaches, including pharmacological interventions, supplements or diets, genetic modifications, and training programs.
- Published
- 2021
- Full Text
- View/download PDF
22. What is 'Hyper' in the ALS Hypermetabolism?
- Author
-
Alberto Ferri and Roberto Coccurello
- Subjects
Pathology ,RB1-214 - Abstract
The progressive and fatal loss of upper (brain) and lower (spinal cord) motor neurons and muscle denervation concisely condenses the clinical picture of amyotrophic lateral sclerosis (ALS). Despite the multiple mechanisms believed to underlie the selective loss of motor neurons, ALS aetiology remains elusive and obscure. Likewise, there is also a cluster of alterations in ALS patients in which muscle wasting, body weight loss, eating dysfunction, and abnormal energy dissipation coexist. Defective energy metabolism characterizes the ALS progression, and such paradox of energy balance stands as a challenge for the understanding of ALS pathogenesis. The hypermetabolism in ALS will be examined from tissue-specific energy imbalance (e.g., skeletal muscle) to major energetic pathways (e.g., AMP-activated protein kinase) and whole-body energy alterations including glucose and lipid metabolism, nutrition, and potential involvement of interorgan communication. From the point of view here expressed, the hypermetabolism in ALS should be evaluated as a magnifying glass through which looking at the ALS pathogenesis is from a different perspective in which defective metabolism can disclose novel mechanistic interpretations and lines of intervention.
- Published
- 2017
- Full Text
- View/download PDF
23. Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1
- Author
-
Alberto Ferri, Monica Nencini, Mauro Cozzolino, Paolo Carrara, Sandra Moreno, and Maria Teresa Carrì
- Subjects
Amyotrophic lateral sclerosis ,ALS ,Interferon γ ,Neuroinflammation ,SOD ,TNFα ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Recent studies indicate that molecular signals from microglia determine disease progression in transgenic mice overexpressing mutant superoxide dismutase (mutSOD1) typical of amyotrophic lateral sclerosis patients and that toxicity of mutSOD1 in motor neurons descends from its tendency to associate with mitochondria.To assess whether the neurotoxicity of mutSOD1 is influenced by signals from glia, we challenged motoneuronal cells overexpressing either wild-type or mutant SOD1 with inflammatory cytokines. We have obtained evidence that combined treatment with tumor necrosis factor α and interferon γ increases the fraction of both wtSOD1 and mutSOD1 associated with mitochondria, but these inflammatory cytokines dramatically alter morphological features and functionality of mitochondria only in cells expressing mutSOD1. As an effect downstream the increase in mitochondria-associated mutSOD1, the ratio between reduced and oxidized glutathione further shifts toward the oxidized form in this compartment and a clear death phenotype is evoked upon treatment with inflammatory cytokines. These results suggest that signals coming from non-neuronal cells contribute to death of motor neurons induced by mutSOD1 through reinforcement of mitochondrial damage.
- Published
- 2008
- Full Text
- View/download PDF
24. CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice.
- Author
-
Sara Travaglione, Giulia Ballan, Andrea Fortuna, Alberto Ferri, Marco Guidotti, Gabriele Campana, Carla Fiorentini, and Stefano Loizzo
- Subjects
Medicine ,Science - Abstract
Epilepsy, one of the most common conditions affecting the brain, is characterized by neuroplasticity and brain cell energy defects. In this work, we demonstrate the ability of the Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1) to counteract epileptiform phenomena in inbred DBA/2J mice, an animal model displaying genetic background with an high susceptibility to induced- and spontaneous seizures. Via modulation of the Rho GTPases, CNF1 regulates actin dynamics with a consequent increase in spine density and length in pyramidal neurons of rat visual cortex, and influences the mitochondrial homeostasis with remarkable changes in the mitochondrial network architecture. In addition, CNF1 improves cognitive performances and increases ATP brain content in mouse models of Rett syndrome and Alzheimer's disease. The results herein reported show that a single dose of CNF1 induces a remarkable amelioration of the seizure phenotype, with a significant augmentation in neuroplasticity markers and in cortex mitochondrial ATP content. This latter effect is accompanied by a decrease in the expression of mitochondrial fission proteins, suggesting a role of mitochondrial dynamics in the CNF1-induced beneficial effects on this epileptiform phenotype. Our results strongly support the crucial role of brain energy homeostasis in the pathogenesis of certain neurological diseases, and suggest that CNF1 could represent a putative new therapeutic tool for epilepsy.
- Published
- 2015
- Full Text
- View/download PDF
25. Apaf1 mediates apoptosis and mitochondrial damage induced by mutant human SOD1s typical of familial amyotrophic lateral sclerosis
- Author
-
Mauro Cozzolino, Alberto Ferri, Elisabetta Ferraro, Giuseppe Rotilio, Francesco Cecconi, and Maria Teresa Carrì
- Subjects
Familial amyotrophic lateral sclerosis ,Mitochondria ,Neurodegeneration ,Oxidative stress ,Superoxide dismutase ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Several studies have indicated that apoptotic pathways are responsible for the loss of motor neurons that constitute the hallmark of amyotrophic lateral sclerosis (ALS). In this study, we demonstrate that apoptosis induced by the expression of several mutant Cu,Zn superoxide dismutases (SOD1) typical of familial ALS is mediated by Apaf1, a scaffold protein involved in neural development. Using different cell lines of neuronal origin and modulating the expression of both mutant SOD1s and Apaf1, we show that the removal of Apaf1 prevents cells death. Interestingly, intercepting activation of the caspases cascade is also effective in preventing both the mitochondrial damage and the increase in the production of reactive oxygen species induced by fALS-SOD1, even in the presence of cytochrome c release.This death pathway may be crucial also for the pathogenesis of the sporadic form of the disease, where markers of increased oxidative stress and mitochondria damage have been found.
- Published
- 2006
- Full Text
- View/download PDF
26. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine
- Author
-
Simone Beretta, Gessica Sala, Laura Mattavelli, Chiara Ceresa, Arianna Casciati, Alberto Ferri, Maria Teresa Carrì, and Carlo Ferrarese
- Subjects
Amyotrophic lateral sclerosis ,SOD1 ,Oxidative stress ,Mitochondrial function ,n-Acetylcysteine ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
We report that the expression of mutant G93A copper/zinc superoxide dismutase (SOD1), associated with familial amyotrophic lateral sclerosis, specifically causes a decrease in MTT reduction rate and ATP levels and an increase in both cytosolic and mitochondrial reactive oxygen species (ROS) production in human neuroblastoma SH-SY5Y cells compared to cells overexpressing wild-type SOD1 and untransfected cells. Exposure to N-acetylcysteine lowers ROS production and returns mitochondrial functional assays to control levels. No large aggregates of human SOD1 are detectable under basal growth conditions in any of the investigated cell lines. After proteasome activity inhibition, SOD1 aggregates can be detected exclusively in G93A-SOD1 cells, even though they do not per se enhance cell death compared to control cell lines. Our findings indicate that mitochondrial homeostasis is affected by mutant SOD1-generated ROS independently from the formation of aggregates and that this alteration is reversed by antioxidants.
- Published
- 2003
- Full Text
- View/download PDF
27. CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease.
- Author
-
Stefano Loizzo, Roberto Rimondini, Sara Travaglione, Alessia Fabbri, Marco Guidotti, Alberto Ferri, Gabriele Campana, and Carla Fiorentini
- Subjects
Medicine ,Science - Abstract
Overexpression of pro-inflammatory cytokines and cellular energy failure are associated with neuroinflammatory disorders, such as Alzheimer's disease. Transgenic mice homozygous for human ApoE4 gene, a well known AD and atherosclerosis animal model, show decreased levels of ATP, increased inflammatory cytokines level and accumulation of beta amyloid in the brain. All these findings are considered responsible for triggering cognitive decline. We have demonstrated that a single administration of the bacterial E. coli protein toxin CNF1 to aged apoE4 mice, beside inducing a strong amelioration of both spatial and emotional memory deficits, favored the cell energy restore through an increment of ATP content. This was accompanied by a modulation of cerebral Rho and Rac1 activity. Furthermore, CNF1 decreased the levels of beta amyloid accumulation and interleukin-1β expression in the hippocampus. Altogether, these data suggest that the pharmacological modulation of Rho GTPases by CNF1 can improve memory performances in an animal model of Alzheimer's disease via a control of neuroinflammation and a rescue of systemic energy homeostasis.
- Published
- 2013
- Full Text
- View/download PDF
28. Correction: CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease.
- Author
-
Stefano Loizzo, Roberto Rimondini, Sara Travaglione, Alessia Fabbri, Marco Guidotti, Alberto Ferri, Gabriele Campana, and Carla Fiorentini
- Subjects
Medicine ,Science - Published
- 2013
- Full Text
- View/download PDF
29. Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a mouse model of Friedreich’s ataxia
- Author
-
Riccardo Turchi, Francesca Sciarretta, Marta Tiberi, Matteo Audano, Silvia Pedretti, Concetta Panebianco, Valentina Nesci, Valerio Pazienza, Alberto Ferri, Simone Carotti, Valerio Chiurchiù, Nico Mitro, Daniele Lettieri-Barbato, and Katia Aquilano
- Abstract
Friedreich’s ataxia (FA) is a genetic neurodegenerative disease caused by mutation inFXNgene encoding for the mitochondrial protein frataxin (FXN). Patients with FA display an increased risk of developing diabetes that may aggravate disease prognosis. Recent studies have indicated that in addition to increased visceral adiposity, FA patients undergo a low-grade inflammatory state. The expansion of white adipose tissue (WAT) plays a fundamental role in the development of type 2 diabetes as it becomes insulin-resistant and a source of inflammatory molecules (adipokines). In this work, we have characterized visceral WAT (vWAT) at metabolic and immunological level in a murine FA model (KIKO) to test whether dysfunction of vWAT could be involved in FA metabolic complications. Through RNAseq analyses we found an alteration of inflammatory, angiogenesis and fibrosis genes in vWAT of KIKO mice. We also found other diabetes-related hallmarks such as increased lipid droplet size, immune cell infiltration and increased expression of pro-inflammatory cytokines. In addition, by targeted metabolomics we disclosed a raise in lactate production, an event usually associated with obesity and diabetes and that triggers activation of vWAT resident macrophages. To reproduce anin vitromodel of FA, we downregulated FXN protein in cultured white adipocytes and recapitulated the diabetes-like features observed in vWAT. Real time monitoring of adipocyte metabolism evidenced metabolic rewiring towards glycolysis according to increased lactate production. Analysis of fecal samples revealed a reduction of some butyrate-producing bacteria in KIKO mice. As this microbiota derived short-chain fatty was demonstrated to exert anti-diabetic function, we fed KIKO mice with a butyrate-enriched diet for 16 weeks. This dietary approach limited vWAT alterations and mitigated other diabetes-like signatures both inin vitroandin vivomodels.In conclusion, this study identified vWAT as an important player in the onset of metabolic complications typical of FA and suggests butyrate as safe and promising adjuvant tool to treat metabolic complications in FA.
- Published
- 2023
30. Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease
- Author
-
Tommaso Schirinzi, Illari Salvatori, Henri Zenuni, Piergiorgio Grillo, Cristiana Valle, Giuseppina Martella, Nicola Biagio Mercuri, and Alberto Ferri
- Subjects
synaptopathy ,tau Proteins ,Settore MED/26 ,Catalysis ,neuroinflammation ,Inorganic Chemistry ,Adenosine Triphosphate ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,Spectroscopy ,Amyloid beta-Peptides ,immunometabolic pathway ,Respiration ,Organic Chemistry ,biomarkers ,mitochondria ,Parkinson’s disease ,PBMCs ,Seahorse ,Parkinson Disease ,General Medicine ,Peptide Fragments ,Computer Science Applications ,Mitochondria ,Leukocytes, Mononuclear ,alpha-Synuclein ,Biomarkers - Abstract
Mitochondria are central in the pathogenesis of Parkinson’s disease (PD), as they are involved in oxidative stress, synaptopathy, and other immunometabolic pathways. Accordingly, they are emerging as a potential neuroprotection target, although further human-based evidence is needed for therapeutic advancements. This study aims to shape the pattern of mitochondrial respiration in the blood leukocytes of PD patients in relation to both clinical features and the profile of cerebrospinal fluid (CSF) biomarkers of neurodegeneration. Mitochondrial respirometry on the peripheral blood mononucleate cells (PBMCs) of 16 PD patients and 14 controls was conducted using Seahorse Bioscience technology. Bioenergetic parameters were correlated either with standard clinical scores for motor and non-motor disturbances or with CSF levels of α-synuclein, amyloid-β peptides, and tau proteins. In PD, PBMC mitochondrial basal respiration was normal; maximal and spare respiratory capacities were both increased; and ATP production was higher, although not significantly. Maximal and spare respiratory capacity was directly correlated with disease duration, MDS-UPDRS part III and Hoehn and Yahr motor scores; spare respiratory capacity was correlated with the CSF amyloid-β-42 to amyloid-β-42/40 ratio. We provided preliminary evidence showing that mitochondrial respiratory activity increases in the PBMCs of PD patients, probably following the compensatory adaptations to disease progression, in contrast to the bases of the neuropathological substrate.
- Published
- 2022
31. Differences in CSF Biomarkers Profile of Patients with Parkinson's Disease Treated with MAO-B Inhibitors in Add-On
- Author
-
Tommaso Schirinzi, Nicola Biagio Mercuri, Cristiana Valle, Alberto Ferri, Roberta Bovenzi, Clara Simonetta, Piergiorgio Grillo, Niccolò Candelise, and Henri Zenuni
- Subjects
Monoamine Oxidase Inhibitors ,General Neuroscience ,Selegiline ,Lactates ,Humans ,Parkinson Disease ,General Medicine ,Biomarkers - Abstract
Monoamine oxidase type B inhibitors (iMAO-Bs) are a class of largely-used antiparkinsonian agents that, based on experimental evidence, are supposed to exert different degrees of neuroprotection in Parkinson's disease (PD). However, clinical proofs on this regard are very scarce. Since cerebrospinal fluid (CSF) reflects pathological changes occurring at brain level, we examined the neurodegeneration-related CSF biomarkers profile of PD patients under chronic treatment with different iMAO-Bs to identify biochemical signatures suggestive for differential neurobiological effects.Thirty-five PD patients under chronic treatment with different iMAO-Bs in add-on to levodopa were enrolled and grouped in rasagiline (n = 13), selegiline (n = 9), safinamide (n = 13). Respective standard clinical scores for motor and non-motor disturbances, together with CSF biomarkers of neurodegeneration levels (amyloid- β -42, amyloid- β -40, total and 181-phosphorylated tau, and lactate) were collected and compared among the three iMAO-B groups.No significant clinical differences emerged among the iMAO-B groups. CSF levels of tau proteins and lactate were instead different, resulting higher in patients under selegiline than in those under rasagiline and safinamide.Although preliminary and limited, this study indicates that patients under different iMAO-Bs may present distinct profiles of CSF neurodegeneration-related biomarkers, probably because of the differential neurobiological effects of the drugs. Larger studies are now needed to confirm and extend these initial observations.
- Published
- 2022
32. Motivational Factors Predicting the Selection of Elective Physical Education: Prospective in High School Students
- Author
-
Alberto Ferriz-Valero, Luis García-González, Salvador García-Martínez, and Javier Fernández-Río
- Subjects
motivation ,adolescents ,teaching style ,achievement goals ,self-determination theory ,Philosophy. Psychology. Religion ,Psychology ,BF1-990 - Abstract
The choice of optional physical education could be conditioned by personal elements, such as goals or motivation, or contextual, such as perceived teaching behaviour. The aims of this study were to analyse the differences between students who chose (or not) Physical Education and to determine to what extent goal orientations, motivational regulations, and perceived teaching behaviors predict that decision. A sample of 756 adolescents from 14 public centres in Valencian Region enrolled in second grade of high school (Mage 17.06, SD = 0.75), of which 422 were girls (55.8%) participated in the study. Students who voluntarily chose Physical Education presented a different motivational profile, scored higher in all approximation goals (and avoidance), intrinsic motivation, identified and introjected and lower in amotivation. They also showed a marked profile in the teaching styles perceived in the subject in the past (support for autonomy and structured). Finally, the factor that best predicted this choice was the participatory behavior perceived by the student (teaching style supporting autonomy), followed by the orientation of the goal of approximation-task, dominant behaviors (negative), and intrinsic regulation.
- Published
- 2024
- Full Text
- View/download PDF
33. An integrated decision‐making framework for corporate sustainability
- Author
-
Michele Molin, Lisa Pizzol, Marco Pesce, Alessandro Maura, Matteo Civiero, Elisa Gritti, Simone Giotto, Alberto Ferri, Lorenzo Liguoro, Carlo Bagnoli, and Elena Semenzin
- Subjects
integrated sustainability framework ,Corporate Social Responsibility ,strategic sustainable development ,Settore SECS-P/07 - Economia Aziendale ,Strategy and Management ,Corporate Social Responsibility, Corporate Sustainability, environmental sustainability, integrated sustainability framework,strategic sustainable development, sustainability management ,Corporate Sustainability ,sustainability management ,Management, Monitoring, Policy and Law ,Development ,environmental sustainability ,Settore CHIM/12 - Chimica dell'Ambiente e dei Beni Culturali - Published
- 2022
34. Repurposing of Trimetazidine for Amyotrophic Lateral Sclerosis: a study in SOD1 G93A mice
- Author
-
Michela Gloriani, Luisa Pieroni, Cristiana Valle, Cyril Quessada, Silvia Scaricamazza, Elisabetta Ferraro, Giacomo Giacovazzo, Gabriella Dobrowolny, Hao Wang, Valentina Nesci, Antonio Musarò, Niccolò Candelise, Cinzia Volonté, Illari Salvatori, Shyuan T. Ngo, Jean-Philippe Loeffler, Alberto Ferri, Frédérique René, Tesfaye Wolde Tefera, Susanna Amadio, Aniello Primiano, Andrea Urbani, Elisa Lepore, Alessio Torcinaro, Frederik J. Steyn, and Roberto Coccurello
- Subjects
Pharmacology ,Hypermetabolism ,SOD1G93A mice ,Trimetazidine ,amyotrophic lateral sclerosis ,hypermetabolism ,mitochondria ,neurodegeneration ,business.industry ,Neurodegeneration ,Amyotrophic Lateral Sclerosis ,Skeletal muscle ,trimetazidine ,Motor neuron ,Spinal cord ,medicine.disease ,Mitochondria ,medicine.anatomical_structure ,medicine ,Amyotrophic lateral sclerosis ,business ,Neuroinflammation ,medicine.drug - Abstract
Background and purpose: Amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by the degeneration of upper and lower motor neurons, progressive wasting and paralysis of voluntary muscles is currently incurable despite intense research and numerous unsuccessful clinical trials. Although considered as a pure motor neuron disease, increasing evidence indicates that the sole protection of motor neurons by a single target drug is not sufficient to improve the pathological phenotype. We therefore evaluated the therapeutic potential of the multi-target drug, trimetazidine, in SOD1G93A mice. Experimental approach: Trimetazidine is an anti-ischemic drug used for the treatment of coronary artery disease. As a metabolic modulator, Trimetazidine improves glucose metabolism. Furthermore, Trimetazidine enhances mitochondrial metabolism and promotes nerve regeneration, exerting an anti-inflammatory and antioxidant effect. Here, we orally treated SOD1G93A mice with Trimetazidine, solubilized in drinking water at a dose of 20 mg/kg, from disease onset. We assessed the impact of Trimetazidine on disease progression by studying metabolic parameters, grip strength, and histological alterations in skeletal muscle, peripheral nerve and spinal cord. Key results: Trimetazidine administration delays motor function decline, improves muscle performance and metabolism, and significantly extends overall survival of SOD1G93A mice (increased median survival of 16 days and 12.5 days for male and female respectively). Moreover, Trimetazidine prevents the dismantlement of neuromuscular junctions, attenuates motor neuron loss and reduces neuroinflammation in the spinal cord and in peripheral nerves. Conclusion and implications: In SOD1G93A mice, therapeutic effect of Trimetazidine is underpinned by its action on mitochondrial function in skeletal muscle and spinal cord. Keywords: Amyotrophic Lateral Sclerosis; Hypermetabolism; Mitochondria; Neurodegeneration; SOD1G93A mice; Trimetazidine.
- Published
- 2022
- Full Text
- View/download PDF
35. Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition
- Author
-
Verushka Valsecchi, Graham Baker, Carlo Custodero, Yves-Marie Pers, Alberto Pilotto, Alberto Ferri, Sabrina Zora, Hein Raat, Marta M Pisano-González, Delia Peñacoba Maestre, Alberto Cella, Raquel Vazquez Alvarez, and Public Health
- Subjects
Self-assessment ,Gerontology ,business.industry ,Medicine (miscellaneous) ,Context (language use) ,RM1-950 ,frailty ,malnutrition ,medicine.disease ,Health outcomes ,self-assessment ,multidimensional prognostic index ,cognitive deficit ,Malnutrition ,Chronic disease ,Medicine ,Self perceived ,Therapeutics. Pharmacology ,Self management program ,medicine.symptom ,business ,chronic disease ,Cognitive deficit ,Original Research - Abstract
Introduction: The Chronic Disease Self-Management Program (CDSMP) improves self-efficacy and health outcomes in people with chronic diseases. In the context of the EFFICHRONIC project, we evaluated the efficacy of CDSMP in relieving frailty, as assessed by the self-administered version of Multidimensional Prognostic Index (SELFY-MPI), identifying also potential predictors of better response over 6-month follow-up. Methods: The SELFY-MPI explores mobility, basal and instrumental activities of daily living (Barthel mobility, ADL, IADL), cognition (Test Your Memory-TYM Test), nutrition (Mini Nutritional Assessment-Short Form-MNA-SF), comorbidities, medications, and socio-economic conditions (social-familiar evaluation scale-SFES). Participants were stratified in three groups according to the 6-month change of SELFY-MPI: those who improved after CDSMP (Δ SELFY-MPI 0). Multivariable logistic regression was modeled to identify predictors of SELFY-MPI improvement. Results: Among 270 participants (mean age = 61.45 years, range = 26–93 years; females = 78.1%) a benefit from CDSMP intervention, in terms of decrease in the SELFY-MPI score, was observed in 32.6% of subjects. SELFY-MPI improvement was found in participants with higher number of comorbidities (1–2 chronic diseases: adjusted odd ratio (aOR)=2.38, 95% confidence interval (CI) =1.01, 5.58; ⩾ 3 chronic diseases: aOR = 3.34, 95% CI = 1.25, 8.90 vs no chronic disease), poorer cognitive performance (TYM ⩽ 42: aOR = 2.41, 95% CI = 1.12, 5.19 vs TYM > 42) or higher risk of malnutrition (MNA-SF ⩽ 11: aOR = 6.11, 95% CI = 3.15, 11.83 vs MNA-SF > 11). Conclusion: These findings suggest that the CDSMP intervention contributes to decreasing the self-perceived severity of frailty (SELFY-MPI score) in more vulnerable participants with several chronic diseases and lower cognitive performance and nutritional status.
- Published
- 2021
36. Targeting SerpinE1 reverses cellular features of Hutchinson-Gilford progeria syndrome
- Author
-
Chiara Nicoletti, Alberto Ferri, Cristiana Valle, Andrea Bracaglia, Rita Canipari, Giorgia Catarinella, Illari Salvatori, Pier Lorenzo Puri, Lucia Latella, Marilena Taggi, and Paola Procopio
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Mutation ,Progeria ,integumentary system ,business.industry ,nutritional and metabolic diseases ,medicine.disease_cause ,Progerin ,medicine.disease ,Phenotype ,Pathogenesis ,Downregulation and upregulation ,Gene expression ,medicine ,Cancer research ,business ,Lamin - Abstract
Hutchinson-Gilford progeria syndrome (HGPS) is a rare, fatal disease caused by Lamin A mutation, leading to altered nuclear architecture, loss of perinuclear heterochromatin and deregulated gene expression. HGPS patients eventually die by coronary artery disease and cardiovascular alterations. However, how deregulated transcriptional networks at the cellular level impact on the systemic disease phenotype is currently unclear. We have performed a longitudinal genome-wide analysis of gene expression in primary HGPS fibroblasts from patients at two sequential stages of disease that revealed a progressive activation of Rho signaling and SerpinE1, also known as Plasminogen Activator Inhibitor (PAI-1). siRNA-mediated downregulation or pharmacological inhibition of SerpinE1 by TM5441 could revert key pathological features of HGPS in patient-derived fibroblasts, including re-activation of cell cycle progression, reduced DNA damage signaling, decreased expression of pro-fibrotic genes and recovery of mitochondrial defects. These effects were accompanied by reduced levels of Progerin and correction of nuclear abnormalities. These data point to SerpinE1 as a novel potential effector of HGPS pathogenesis and target for therapeutic interventions.
- Published
- 2021
37. Alteraciones genéticas y epi-genéticas del gen PTEN : clave en la relación entre diabetes mellitus tipo 2 y cáncer
- Author
-
Alan Rolando Ayala Schimpf, María Mercedes Formichela, María Betania Mascheroni, Donovan Rivero, Marcela Luján Chamorro, Valeria Portillo, Pedro Darío Zapata, and Cristian Alberto Ferri
- Subjects
Type 2 Diabetes Mellitus ,Polymers and Plastics ,PTEN expression ,Diabetes Mellitus Tipo 2 ,Hypermethylation ,Cáncer ,Hipermetilación ,Cancer ,Expresión de PTEN - Abstract
Fil: Ayala Schimpf, Alan Rolando. Universidad Nacional de Misiones. Facultad de Ciencias Exactas, Químicas y Naturales. Instituto de Biotecnología Misiones “Dra. María Ebe Reca”. Laboratorio de Biotecnología Molecular; Argentina. Fil: Chamorro, Marcela Luján. Clínica Nosiglia (Posadas, Misiones). Laboratorio “Centro Bioquímico de Alta Complejidad”; Argentina. Fil: Portillo, Valeria. Centro de Medicina Preventiva (Posadas, Misiones); Argentina. Fil: Ayala Schimpf, Alan Rolando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Formichela, María Mercedes. Universidad Nacional de Misiones. Facultad de Ciencias Exactas, Químicas y Naturales. Cátedra de Bioquímica Clínica II. Módulo de Farmacia y Bioquímica; Argentina. Fil: Formichela, María Mercedes. Clínica Nosiglia (Posadas, Misiones). Laboratorio “Centro Bioquímico de Alta Complejidad”; Argentina. Fil: Mascheroni, María Betania. Clínica Nosiglia (Posadas, Misiones). Laboratorio “Centro Bioquímico de Alta Complejidad”; Argentina. Fil: Mascheroni, María Betania. Centro de Medicina Preventiva (Posadas, Misiones); Argentina. Fil: Rivero, Donovan. Universidad Nacional de Misiones. Facultad de Ciencias Exactas, Químicas y Naturales. Instituto de Biotecnología Misiones “Dra. María Ebe Reca”. Laboratorio de Biotecnología Molecular; Argentina. Fil: Rivero, Donovan. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Zapata, Pedro Darío. Universidad Nacional de Misiones. Facultad de Ciencias Exactas, Químicas y Naturales. Instituto de Biotecnología Misiones “Dra. María Ebe Reca”. Laboratorio de Biotecnología Molecular; Argentina. Fil: Zapata, Pedro Darío. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Ferri, Cristian Alberto. Universidad Nacional de Misiones. Facultad de Ciencias Exactas, Químicas y Naturales. Instituto de Biotecnología Misiones “Dra. María Ebe Reca”. Laboratorio de Biotecnología Molecular; Argentina. Fil: Ferri, Cristian Alberto. Fundación Héctor A. Barceló. Facultad de Medicina. Instituto Universitario de Ciencias de la Salud; Argentina. Cancer pathogenesis has been associated with genetic and epigenetic alterations that may lead to the inactivation or decrease of tumor-suppressor genes, such as the PTEN gene. In particular, alterations in the PI3K/PTEN signaling pathways are related to abnormalities associated with diabetes, metabolic syndrome, obesity and cardiovascular diseases. The aim of the study was to evaluate whether the expression levels of the PTEN gene, the 32-bp deletion in the PTEN gene, and the methylation in the PTEN promoter are associated with Type 2 Diabetes Mellitus(T2DM) and cancer development. Peripheral blood samples were obtained from a total of 70 patients of both sexes: 40 patients with T2DM and 30 patients with T2DM and cancer(T2DM+C). In this a novel report that assesses the upregulation of PTEN in T2DM, we observed that PTEN expression is higher in T2DM patients than in healthy individuals and markedly lower in T2DM patients with cancer than in T2DM patients without cancer. Hypermethylation of the PTEN promoter is more frequent in T2DM patients with cancer. Genetic and epigenetic alterations of the PTEN gene may be a key in the relationship between T2DM and cancer. PTEN expression may serve as a potential candidate biomarker for cancer development in T2DM patients. La patogenia del cáncer ha sido asociada con alteraciones genéticas y epigenéticas que pueden llevar a la inactivación o subexpresión de genes supresores de tumores, como el gen PTEN. Las alteraciones en las vías de señalización de PI3K/PTEN están relacionadas con anomalías asociadas a diabetes, síndrome metabólico, obesidad y enfermedades cardiovasculares. El objetivo del estudio fue evaluar, si la expresión alterada (subexpresión/ sobreexpresión) del gen PTEN, la deleción de 32 pb y la metilación del promotor, se asocian con diabetes mellitus tipo 2 (DMT2) y el desarrollo de cáncer. Las muestras de sangre periféricas se obtuvieron de un total de 70 pacientes de ambos sexos: 40 pacientes con DMT2 y 30 pacientes con DMT2 y cáncer (DMT2+C). En este trabajo novedoso, se reporta la sobreexpresión de PTEN en DMT2. Observamos que la expresión de PTEN es más alta en pacientes con DMT2 que en individuos sanos y marcadamente menor en pacientes con DMT2+C, en comparación con los pacientes diabéticos sin neoplasias. La hipermetilación del promotor de PTEN es más frecuente en pacientes con DMT2 y cancer. Las alteraciones genéticas y epigenéticas en el gen PTEN podría ser clave en la relación existente entre diabetes y el desarrollo de cancer. La expresión de PTEN puede ser un potencial biomarcador en el desarrollo cancer en pacientes con DMT2.
- Published
- 2021
38. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1
- Author
-
Silvia, Scaricamazza, Illari, Salvatori, Susanna, Amadio, Valentina, Nesci, Alessio, Torcinaro, Giacomo, Giacovazzo, Aniello, Primiano, Michela, Gloriani, Niccolò, Candelise, Luisa, Pieroni, Jean-Philippe, Loeffler, Frederique, Renè, Cyril, Quessada, Tesfaye W, Tefera, Hao, Wang, Frederik J, Steyn, Shyuan T, Ngo, Gabriella, Dobrowolny, Elisa, Lepore, Andrea, Urbani, Antonio, Musarò, Cinzia, Volonté, Elisabetta, Ferraro, Roberto, Coccurello, Cristiana, Valle, and Alberto, Ferri
- Subjects
Male ,Disease Models, Animal ,Mice ,Superoxide Dismutase-1 ,Superoxide Dismutase ,Amyotrophic Lateral Sclerosis ,Drug Repositioning ,Trimetazidine ,Animals ,Female ,Mice, Transgenic ,Neurodegenerative Diseases - Abstract
Amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by the degeneration of upper and lower motor neurons, progressive wasting and paralysis of voluntary muscles and is currently incurable. Although considered to be a pure motor neuron disease, increasing evidence indicates that the sole protection of motor neurons by a single targeted drug is not sufficient to improve the pathological phenotype. We therefore evaluated the therapeutic potential of the multi-target drug used to treatment of coronary artery disease, trimetazidine, in SOD1As a metabolic modulator, trimetazidine improves glucose metabolism. Furthermore, trimetazidine enhances mitochondrial metabolism and promotes nerve regeneration, exerting an anti-inflammatory and antioxidant effect. We orally treated SOD1Trimetazidine administration delays motor function decline, improves muscle performance and metabolism, and significantly extends overall survival of SOD1In SOD1
- Published
- 2021
39. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications
- Author
-
Valeria Manganelli, Maurizio Sorice, Silvia Scaricamazza, Illari Salvatori, Niccolò Candelise, Alberto Ferri, Tina Garofalo, Roberta Misasi, and Cristiana Valle
- Subjects
0301 basic medicine ,TDP-43 ,Review ,Protein aggregation ,chemistry.chemical_compound ,0302 clinical medicine ,neurodegenerative disease ,tau ,Biology (General) ,Spectroscopy ,biology ,intrinsic disorder ,A protein ,Neurodegenerative Diseases ,General Medicine ,Phenotype ,Structural heterogeneity ,Computer Science Applications ,Chemistry ,alpha-Synuclein ,Amyloid ,Amyloid beta ,QH301-705.5 ,Protein domain ,tau Proteins ,Protein Aggregation, Pathological ,Catalysis ,protein aggregation ,Inorganic Chemistry ,Protein Aggregates ,03 medical and health sciences ,alpha synuclein ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,QD1-999 ,Alpha-synuclein ,Organic Chemistry ,Intrinsically Disordered Proteins ,amyloid beta ,phase separation ,prion protein ,030104 developmental biology ,chemistry ,biology.protein ,Biophysics ,Protein Conformation, beta-Strand ,Signalling pathways ,030217 neurology & neurosurgery - Abstract
Intrinsic disorder is a natural feature of polypeptide chains, resulting in the lack of a defined three-dimensional structure. Conformational changes in intrinsically disordered regions of a protein lead to unstable β-sheet enriched intermediates, which are stabilized by intermolecular interactions with other β-sheet enriched molecules, producing stable proteinaceous aggregates. Upon misfolding, several pathways may be undertaken depending on the composition of the amino acidic string and the surrounding environment, leading to different structures. Accumulating evidence is suggesting that the conformational state of a protein may initiate signalling pathways involved both in pathology and physiology. In this review, we will summarize the heterogeneity of structures that are produced from intrinsically disordered protein domains and highlight the routes that lead to the formation of physiological liquid droplets as well as pathogenic aggregates. The most common proteins found in aggregates in neurodegenerative diseases and their structural variability will be addressed. We will further evaluate the clinical relevance and future applications of the study of the structural heterogeneity of protein aggregates, which may aid the understanding of the phenotypic diversity observed in neurodegenerative disorders.
- Published
- 2021
40. Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
- Author
-
Frédérique René, Alberto Ferri, Cristiana Valle, Cyril Quessada, Jean Philippe Loeffler, Shyuan T. Ngo, Alexandra Bouscary, Mécanismes Centraux et Périphériques de la Neurodégénérescence, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuro-sys SAS [Gardanne], Fondazione Santa Lucia [IRCCS], Clinical and Behavioral Neurology [IRCCS Santa Lucia], University of Queensland [Brisbane], Neuro-sys, and Dieterle, Stéphane
- Subjects
Male ,0301 basic medicine ,Prognostic factor ,Pathology ,medicine.medical_specialty ,Amyotrphic Lateral Sclerosis ,QH301-705.5 ,trimetazidine ,[SDV]Life Sciences [q-bio] ,Trimetazidine ,PDK4 ,Review ,Neuromuscular junction ,03 medical and health sciences ,Superoxide Dismutase-1 ,0302 clinical medicine ,hypermetabolism ,Animals ,Humans ,Medicine ,Biology (General) ,Amyotrophic lateral sclerosis ,skeletal muscle ,Muscle, Skeletal ,neuromuscular junction ,business.industry ,Amyotrophic Lateral Sclerosis ,Skeletal muscle ,General Medicine ,Metabolism ,medicine.disease ,3. Good health ,[SDV] Life Sciences [q-bio] ,030104 developmental biology ,medicine.anatomical_structure ,Hypermetabolism ,ALS ,business ,030217 neurology & neurosurgery ,metabolic imbalance ,medicine.drug - Abstract
International audience; Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive and selective loss of motor neurons, amyotrophy and skeletal muscle paralysis usually leading to death due to respiratory failure. While generally considered an intrinsic motor neuron disease, data obtained in recent years, including our own, suggest that motor neuron protection is not sufficient to counter the disease. The dismantling of the neuromuscular junction is closely linked to chronic energy deficit found throughout the body. Metabolic (hypermetabolism and dyslipidemia) and mitochondrial alterations described in patients and murine models of ALS are associated with the development and progression of disease pathology and they appear long before motor neurons die. It is clear that these metabolic changes participate in the pathology of the disease. In this review, we summarize these changes seen throughout the course of the disease, and the subsequent impact of glucose–fatty acid oxidation imbalance on disease progression. We also highlight studies that show that correcting this loss of metabolic flexibility should now be considered a major goal for the treatment of ALS.
- Published
- 2021
41. LIMITAÇÕES OU RESTRIÇÕES DOS DIREITOS FUNDAMENTAIS: APLICABILIDADE DAS TEORIAS INTERNA E EXTERNA
- Author
-
Carlos Alberto Ferri and Moisés Alves de Souza
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Abstract
O presente artigo visa apresentar de forma conceitual e teórica, questões relacionadas ao tema dos direitos fundamentais. O correto uso terminológico da expressão “Direitos fundamentais” e, a distinção quanto ao uso da expressão “Geração” ou “Dimensão” dos Direitos fundamentais. Busca também apresentar se tais direitos são realmente absolutos. Apresenta também de forma conceitual a limitação ou restrição dos direitos fundamentais pela teoria interna e teoria externa sob o prisma da teoria dos direitos fundamentais de Robert Alexy e, por fim, busca apresentar alguns pontos distintivos entre a teoria interna e a teoria externa.
- Published
- 2018
42. Motorización vs. peatonalización: un análisis de la percepción de los usuarios en el centro histórico de Toluca
- Author
-
Alberto Ferriz Gómez, Francisco Javier Rosas Ferrusca, Juan Roberto Calderón Maya, Verónica Miranda Rosales, and Pedro Leobardo Jiménez Sánchez
- Subjects
motorización ,peatonalización ,movilidad urbana ,modo de transporte ,Geography. Anthropology. Recreation ,Geography (General) ,G1-922 - Abstract
. La motorización en las grandes ciudades constituye en la actualidad un factor que demanda alternativas para que los centros urbanos recuperen su funcionalidad y ofrezcan a sus habitantes espacios públicos que prioricen la interacción social. El objetivo de este artículo radica en analizar la percepción de la población que por algún motivo acude al centro histórico de la ciudad de Toluca, México, en torno a su peatonalización. Para tal efecto, se diseñó una encuesta semiestructurada que recopila la opinión de los visitantes a este polígono, considerando los motivos de viaje, los costos, los modos de transporte y su postura a favor o en contra de la peatonalización. Los resultados indican que si bien existe un porcentaje alto (69%) que apoya las iniciativas para evitar la congestión vehicular y ejecutar acciones de mejora, también es una realidad que la peatonalización no puede ser total: un 53,5% de la población está a favor de peatonalizar parcialmente, es decir, solo algunas vialidades, mientras que el 31% prefiere mantener las condiciones tal y como se encuentran actualmente a pesar de los efectos negativos que prevalecen. Estas cifras reflejan que las autoridades responsables de la movilidad urbana en el ámbito local y estatal deben asumir el reto de diseñar alternativas para avanzar hacia esquemas más sustentables que contrarresten las externalidades derivadas del incremento del índice de motorización en el centro histórico de Toluca.
- Published
- 2024
- Full Text
- View/download PDF
43. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?
- Author
-
Cristiana Valle, Illari Salvatori, Silvia Scaricamazza, and Alberto Ferri
- Subjects
Weakness ,amyotrophic lateral sclerosis ,muscle ,physical activity ,genetic intervention ,Disease ,Degeneration (medical) ,Review ,medicine ,Paralysis ,Humans ,Amyotrophic lateral sclerosis ,skeletal muscle ,Muscle, Skeletal ,lcsh:QH301-705.5 ,physical ac-tivity ,business.industry ,Skeletal muscle ,General Medicine ,Motor neuron ,medicine.disease ,skeletal ,pharmacological approaches ,Metabolism Mitochondria ,medicine.anatomical_structure ,lcsh:Biology (General) ,Etiology ,humans ,medicine.symptom ,business ,Neuroscience - Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the selective degeneration of upper and lower motor neurons and by the progressive weakness and paralysis of voluntary muscles. Despite intense research efforts and numerous clinical trials, it is still an incurable disease. ALS had long been considered a pure motor neuron disease; however, recent studies have shown that motor neuron protection is not sufficient to prevent the course of the disease since the dismantlement of neuromuscular junctions occurs before motor neuron degeneration. Skeletal muscle alterations have been described in the early stages of the disease, and they seem to be mainly involved in the “dying back” phenomenon of motor neurons and metabolic dysfunctions. In recent years, skeletal muscles have been considered crucial not only for the etiology of ALS but also for its treatment. Here, we review clinical and preclinical studies that targeted skeletal muscles and discuss the different approaches, including pharmacological interventions, supplements or diets, genetic modifications, and training programs.
- Published
- 2021
44. Overexpression of neuroglobin promotes energy metabolism and autophagy induction in human neuroblastoma SH-SY5Y cells
- Author
-
Illari Salvatori, Daniela Caissutti, Margherita Ruoppolo, Cristiana Valle, Valeria Manganelli, Maurizio Sorice, Antonella Capozzi, Alberto Ferri, Marianna Caterino, Michele Costanzo, Tina Garofalo, Roberta Misasi, Manganelli, V, Salvatori, I, Costanzo, M, Capozzi, A, Caissutti, D, Caterino, M, Valle, C, Ferri, A, Sorice, M, Ruoppolo, M, Garofalo, T, and Misasi, R
- Subjects
autophagy ,tumor ,SH-SY5Y ,energy metabolism ,label-free proteomics ,mitochondria ,neuroglobin ,sh-sy5y neuroblastoma cells ,adenosine triphosphate ,cell line ,gene expression regulation, neoplastic ,humans ,microtubule-associated proteins ,neuroblastoma ,oxygen consumption ,proteome ,sequestosome-1 protein ,QH301-705.5 ,Oxidative phosphorylation ,Mitochondrion ,Article ,Downregulation and upregulation ,Cell Line, Tumor ,Globin ,Biology (General) ,SH-SY5Y neuroblastoma cell ,Label-free proteomic ,Chemistry ,Autophagy ,General Medicine ,gene expression regulation ,Cell biology ,neoplastic ,Gene Expression Regulation, Neoplastic ,Neuroglobin ,SH-SY5Y neuroblastoma cells ,Cellular model - Abstract
Neuroglobin (NGB) is an O2-binding globin mainly expressed in the central and peripheral nervous systems and cerebrospinal fluid. Previously, it was demonstrated that NGB overexpression protects cells from hypoxia-induced death. To investigate processes promoted by NGB overexpression, we used a cellular model of neuroblastoma stably overexpressing an NGB-FLAG construct. We used a proteomic approach to identify the specific profile following NGB overexpression. To evaluate the role of NGB overexpression in increasing energetic metabolism, we measured oxygen consumption rate (OCR) and the extracellular acidification rate through Seahorse XF technology. The effect on autophagy induction was evaluated by analyzing SQSTM1/p62 and LC3-II expression. Proteomic analysis revealed several differentially regulated proteins, involved in oxidative phosphorylation and integral mitochondrial proteins linked to energy metabolism. The analysis of mitochondrial metabolism demonstrated that NGB overexpression increases mitochondrial ATP production. Indeed, NGB overexpression enhances bioenergetic metabolism, increasing OCR and oxygen consumption. Analysis of autophagy induction revealed an increase of LC3-II together with a significant decrease of SQSTM1/p62, and NGB-LC3-II association during autophagosome formation. These results highlight the active participation of NGB in several cellular processes that can be upregulated in response to NGB overexpression, playing a role in the adaptive response to stress in neuroblastoma cells.
- Published
- 2021
45. Estilos motivadores docentes y directividad en Educación Física
- Author
-
Juan Antonio Moreno-Murcia, Miguel Saorín-Pozuelo, Salvador Baena-Morales, Alberto Ferriz-Valero, and Julio Barrachina-Peris
- Subjects
adherencia a la práctica ,clima aprendizaje positivo ,competencia motriz ,motivación autónoma ,perfiles motivacionales ,Special aspects of education ,LC8-6691 ,Sports ,GV557-1198.995 - Abstract
La intervención del docente de Educación Física puede ser más eficaz si emplea determinados estilos motivadores, ayudando a generar un entorno de aprendizaje positivo y a promover hábitos de vida activos. Sin embargo, si se percibe como una experiencia negativa podría desmotivar al estudiante y provocar rechazo hacia la práctica, poniendo en riesgo su proceso de alfabetización motriz. Siguiendo un diseño transversal-correlacional, este estudio tuvo como principal objetivo analizar las relaciones entre los estilos motivadores de los docentes y la directividad en Educación Física. Participaron 500 estudiantes de secundaria. Se utilizó la escala SIS para determinar el estilo interpersonal docente y la escala PCT para evaluar la directividad. Los resultados indicaron que las dimensiones de la escala correlacionan de forma positiva y significativa entre sí, exceptuando el Caos, que lo hace de forma negativa con Apoyo a la Autonomía y Estructurado. La dimensión Control no arrojó ninguna correlación con el resto de las dimensiones evaluadas. Además, el análisis clúster mostró dos perfiles de percepción del estilo motivador docente: uno con mayor carga directiva, llamado “dominante”, y otro perfil más autónomo, denominado “adaptativo”. Los resultados revelan vínculos positivos entre el estilo motivador adaptativo, que apoya a la autonomía del estudiante en un clima de aprendizaje positivo y estructurado, y negativos con la desatención y el abandono de la actividad. Estos hallazgos sugieren que el estilo motivador adaptativo en Educación Física implica al estudiante de manera más autónoma en las tareas y puede ayudar a crear situaciones de aprendizaje positivas que fomenten la adherencia a la práctica.
- Published
- 2024
- Full Text
- View/download PDF
46. The Effect of a ‘Humanistic’ Intervention on the Social Responsibility of University Students
- Author
-
Olalla García-Taibo, Salvador Baena-Morales, Arturo Cadenas, Jaime Vázquez, and Alberto Ferriz-Valero
- Subjects
ethics ,religion ,SDGs ,sustainable development ,sustainability ,higher education ,Religions. Mythology. Rationalism ,BL1-2790 - Abstract
Today’s youth navigate a complex balance between traditional and modern values in a changing world. In this context, education plays a crucial role in transforming society and promoting values that align with the Sustainable Development Goals, such as justice and equality, with Ethics and Christianity supporting these principles. Moreover, Physical Education (PE) is highlighted as a tool for promoting moral development and social inclusion; however, gaps exist in studies focusing on the integration of Ethics and Christian values in PE and sports. The aim of this study was to evaluate the impact of an intervention in the subjects of Ethics and Christianity on social responsibility among university students in PE Sciences. The design of this study was quasi-experimental with quantitative pre- and post-test measures and three groups (one Control Group). The sample comprised 95 students who responded to the University Social Responsibility Scale. Experimental Group 1 participated in Christianity class, and Experimental Group 2 in Ethics class. A Mann–Whitney U, Wilcoxon test, and ANOVA were used. The effect associated with the group variable was confirmed. We have partially affirmed that ethical and religious intervention positively influences students’ perception and practice of social responsibility. Future studies should explore pedagogical models that effectively enhance social responsibility among university students.
- Published
- 2024
- Full Text
- View/download PDF
47. Playing towards Motivation: Gamification and University Students in Physical Activity!
- Author
-
Victor Javier Sotos-Martinez, Salvador Baena-Morales, Manuel Sanchez-De Miguel, and Alberto Ferriz-Valero
- Subjects
methodology innovation ,gamified learning ,motivational regulation ,university ,physical education ,Education - Abstract
There is currently concern about the decrease in physical activity participation among university students. To address this issue, different pedagogical approaches have been developed to improve participants’ motivation, with gamification standing out among them. Gamification integrates game design elements into learning environments to increase responsibility, motivation, and engagement in physical activities in different educational stages through intrinsic and extrinsic rewards, although evidence is limited and diverse. Therefore, this study investigates how gamification affects the motivational profile of university students in the context of physical activity. The study was conducted with university students of Physical Activity and Sports Sciences (n = 72), using an experimental design that included a gamified group (GG) and a control group (CG) without gamification. A questionnaire was used to measure motivation before and after the intervention. The results showed a significant increase in intrinsic motivation and a decrease in amotivation in the gamified group, while no significant changes were observed in the control group. However, there were increases in extrinsic motivation in both groups. These findings suggest that gamification can be effective in improving intrinsic motivation and reducing amotivation in university students for physical activity as well as enhancing extrinsic motivation considering the rewards used.
- Published
- 2024
- Full Text
- View/download PDF
48. Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis
- Author
-
Robert D. Henderson, Sarah Chapman, Dean Kelk, Llion A. Roberts, W. Matthew Leevy, Cristiana Valle, Rui Li, Elyse Wimberger, Alberto Ferri, Frederik J. Steyn, Jeff S. Coombes, Pamela A. McCombe, Shyuan T. Ngo, T. Y. Xie, Tesfaye Wolde Tefera, Jean-Philippe Loeffler, Timothy J. Tracey, Frédérique René, Siobhan E Kirk, Fleur C. Garton, University of Southern Queensland (USQ), Royal Brisbane & Women's Hospital [Brisbane, Australia] (RBWH), The Wesley Hospital [Auchenflower, Australia] (TWH), Griffith University [Brisbane], University of Notre Dame [Indiana] (UND), Fondazione Santa Lucia [IRCCS], Clinical and Behavioral Neurology [IRCCS Santa Lucia], Institute of Translational Pharmacology - Istituto di Farmacologia Traslazionale [Roma] (IFT), Consiglio Nazionale delle Ricerche [Roma] (CNR), Mécanismes Centraux et Périphériques de la Neurodégénérescence, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Dieterle, Stéphane
- Subjects
medicine.medical_specialty ,amyotrophic lateral sclerosis ,[SDV]Life Sciences [q-bio] ,Superoxide dismutase ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,hypermetabolism ,Glycolysis ,Amyotrophic lateral sclerosis ,skeletal muscle ,Beta oxidation ,fatty acid oxidation ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,biology ,AcademicSubjects/SCI01870 ,General Engineering ,Skeletal muscle ,Fatty acid ,glucose oxidation ,medicine.disease ,[SDV] Life Sciences [q-bio] ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Hypermetabolism ,biology.protein ,Original Article ,AcademicSubjects/MED00310 ,Flux (metabolism) ,030217 neurology & neurosurgery - Abstract
Amyotrophic lateral sclerosis is characterized by the degeneration of upper and lower motor neurons, yet an increasing number of studies in both mouse models and patients with amyotrophic lateral sclerosis suggest that altered metabolic homeostasis is also a feature of disease. Pre-clinical and clinical studies have shown that modulation of energy balance can be beneficial in amyotrophic lateral sclerosis. However, the capacity to target specific metabolic pathways or mechanisms requires detailed understanding of metabolic dysregulation in amyotrophic lateral sclerosis. Here, using the superoxide dismutase 1, glycine to alanine substitution at amino acid 93 (SOD1G93A) mouse model of amyotrophic lateral sclerosis, we demonstrate that an increase in whole-body metabolism occurs at a time when glycolytic muscle exhibits an increased dependence on fatty acid oxidation. Using myotubes derived from muscle of amyotrophic lateral sclerosis patients, we also show that increased dependence on fatty acid oxidation is associated with increased whole-body energy expenditure. In the present study, increased fatty acid oxidation was associated with slower disease progression. However, within the patient cohort, there was considerable heterogeneity in whole-body metabolism and fuel oxidation profiles. Thus, future studies that decipher specific metabolic changes at an individual patient level are essential for the development of treatments that aim to target metabolic pathways in amyotrophic lateral sclerosis., In superoxide dismutase 1, glycine to alanine substitution at amino acid 93 (SOD1G93A) mice, increased whole-body metabolism occurs alongside fat depletion and increased fatty acid oxidation in glycolytic muscle. Myotubes from patients with amyotrophic lateral sclerosis have increased fatty acid oxidation, and this is associated with increased whole-body energy expenditure. Increased fatty acid oxidation may sustain energy supply to slow disease., Graphical Abstract Graphical Abstract
- Published
- 2020
- Full Text
- View/download PDF
49. Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis (ALS)
- Author
-
W. Matthew Leevy, Elyse Wimberger, Sarah Chapman, Jean-Philippe Loeffler, Cristiana Valle, Frédérique René, Pamela A. McCombe, Siobhan E Kirk, Timothy J. Tracey, T. Y. Xie, Dean Kelk, Robert D. Henderson, Llion A. Roberts, Frederik J. Steyn, Shyuan T. Ngo, Alberto Ferri, Jeff S. Coombes, Fleur C. Garton, and Tesfaye Wolde Tefera
- Subjects
chemistry.chemical_classification ,0303 health sciences ,medicine.medical_specialty ,Fatty acid ,Skeletal muscle ,Metabolism ,medicine.disease ,03 medical and health sciences ,Metabolic pathway ,0302 clinical medicine ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Internal medicine ,medicine ,Glycolysis ,Amyotrophic lateral sclerosis ,Flux (metabolism) ,Beta oxidation ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of upper and lower motor neurons, yet an increasing number of studies in both mouse models and patients with ALS suggest that altered metabolic homeostasis is a feature of disease. Pre-clinical and clinical studies have shown that modulation of energy balance can be beneficial in ALS. However, our capacity to target specific metabolic pathways or mechanisms requires detailed understanding of metabolic dysregulation in ALS. Here, using the SOD1G93Amouse model of ALS, we demonstrate that an increase in whole-body metabolism occurs at a time when glycolytic muscle exhibits an increased dependence on fatty acid oxidation. Using myotubes derived from muscle of ALS patients, we also show that increased dependence on fatty acid oxidation is associated with increased whole-body energy expenditure. In the present study, increased fatty acid oxidation was associated with slower disease progression. However, we observed considerable heterogeneity in whole-body metabolism and fuel oxidation profiles across our patient cohort. Thus, future studies that decipher specific metabolic changes at an individual patient level are essential for the development of treatments that aim to target metabolic pathways in ALS.
- Published
- 2020
- Full Text
- View/download PDF
50. Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target
- Author
-
Roberto Coccurello, Fabio Giannini, Constantin Heil, Jean Philippe Loeffler, Stefania Battistini, Illari Salvatori, Marco Rosina, Nila Volpi, Daisy Proietti, Silvia Scaricamazza, Luca Madaro, Giacomo Giacovazzo, Elisabetta Ferraro, Simona Rossi, Frederik J. Steyn, Shyuan T. Ngo, Alberto Ferri, Cristiana Valle, Cyril Quessada, Frédérique René, Fondazione Santa Lucia [IRCCS], Clinical and Behavioral Neurology [IRCCS Santa Lucia], Università degli Studi di Roma Tor Vergata [Roma], Mécanismes Centraux et Périphériques de la Neurodégénérescence, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute of Translational Pharmacology - Istituto di Farmacologia Traslazionale [Roma] (IFT), Consiglio Nazionale delle Ricerche [Roma] (CNR), Università degli Studi di Siena = University of Siena (UNISI), University of Southern Queensland (USQ), University of Pisa - Università di Pisa, Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA), Dieterle, Stéphane, and Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome]
- Subjects
0301 basic medicine ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,Ranolazine ,02 engineering and technology ,Article ,03 medical and health sciences ,Cellular neuroscience ,Internal medicine ,medicine ,lcsh:Science ,Muscle Denervation ,Multidisciplinary ,business.industry ,Skeletal muscle ,Drugs ,cellular neuroscience ,drugs ,molecular neuroscience ,021001 nanoscience & nanotechnology ,Spinal cord ,3. Good health ,[SDV] Life Sciences [q-bio] ,030104 developmental biology ,medicine.anatomical_structure ,Endocrinology ,Cerebral cortex ,Cellular Neuroscience ,Hypermetabolism ,lcsh:Q ,Brainstem ,Molecular Neuroscience ,0210 nano-technology ,business ,medicine.drug - Abstract
Summary Patients with ALS show, in addition to the loss of motor neurons in the spinal cord, brainstem, and cerebral cortex, an abnormal depletion of energy stores alongside hypermetabolism. In this study, we show that bioenergetic defects and muscle remodeling occur in skeletal muscle of the SOD1G93A mouse model of ALS mice prior to disease onset and before the activation of muscle denervation markers, respectively. These changes in muscle physiology were followed by an increase in energy expenditure unrelated to physical activity. Finally, chronic treatment of SOD1G93A mice with Ranolazine, an FDA-approved inhibitor of fatty acid β-oxidation, led to a decrease in energy expenditure in symptomatic SOD1G93A mice, and this occurred in parallel with a robust, albeit temporary, recovery of the pathological phenotype., Graphical Abstract, Highlights • Metabolic switch use occurs early in the skeletal muscle of SOD1G93A mice • Mitochondrial impairment precedes locomotor deficits and evokes catabolic pathways • Sarcolipin upregulation in presymptomatic SOD1G93A mice precedes hypermetabolism • Pharmacological modulation of hypermetabolism improves locomotor performance, Drugs; Molecular Neuroscience; Cellular Neuroscience
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.